Scholarlink

Background <p>Drug-coated balloons (DCB) have promising results in the management of large coronary artery lesions (CAD), still their role in treating small CAD is not well established. We aimed to provide a comprehensive appraisal of the efficacy and safety of DCBs in patients with small CAD.</p> Methods <p>We searched PubMed, Scopus, web of science, Ovid, and Cochrane Central from inception until 30 March, 2023. We included all relevant studies that compared DCB versus drug-eluting stents (DES) in small CAD patients undergoing PCI. We reported clinical outcomes as MACE, all-cause death, cardiac death, MI, TLR, TVR, and stent thrombosis, while angiographic outcomes were late lumen loss (LLL), mean lumen diameter (MLD), net luminal gain (NLG), and in-segment binary restenosis.</p> Results <p>Twenty studies comprising 18,469 patients were included in this meta-analysis. The incidence rate of MACE was 9.4% in the DCB group compared to 9.9% in the DES group, without a significant difference in the risk of MACE (OR = 0.97, 95% CI: 0.77 to 1.22, <i>p</i> = 0.78). Moreover, DCB significantly decreased MLD and NLG compared to DES, with the following values, respectively (MD= -0.19, 95% CI: -0.32 to -0.06, <i>p</i> &lt; 0.001, and MD -0.21, 95% CI: -0.40 to -0.01, <i>p</i> = 0.04). On the other hand, DCB was associated with higher odds in the risk of in-segment binary restenosis (OR 1.66, 95% CI: 1.03 to 2.68, <i>p</i> = 0.04).</p> Conclusion <p>DCB is an alternative approach to DES in the management of small CAD and should be validated in daily clinical practice.</p> Prospero registration <p>CRD42023413068.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Drug-coated balloons versus drug-eluting stents in patients with small coronary artery disease: an updated meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月30日

查看全文
  • Ahmed Abdelaziz,
  • Hanaa Elsayed,
  • Karim Atta,
  • Muhammad Desouky,
  • Mahmoud Gomaa,
  • Hallas Kadhim,
  • Ahmed Mechi,
  • Mohamed Abdelaziz,
  • Mahmoud Ezzat,
  • Manar Alaa Mabrouk,
  • Mohamed Hatem Ellabban,
  • Emad Addin Zawaneh,
  • Abdelrahman Hafez,
  • Mohamed Yasser Elnaggar,
  • Ahmed O. Sena,
  • Ahmed Bahnasy,
  • Emad Singer

摘要

Background

Drug-coated balloons (DCB) have promising results in the management of large coronary artery lesions (CAD), still their role in treating small CAD is not well established. We aimed to provide a comprehensive appraisal of the efficacy and safety of DCBs in patients with small CAD.

Methods

We searched PubMed, Scopus, web of science, Ovid, and Cochrane Central from inception until 30 March, 2023. We included all relevant studies that compared DCB versus drug-eluting stents (DES) in small CAD patients undergoing PCI. We reported clinical outcomes as MACE, all-cause death, cardiac death, MI, TLR, TVR, and stent thrombosis, while angiographic outcomes were late lumen loss (LLL), mean lumen diameter (MLD), net luminal gain (NLG), and in-segment binary restenosis.

Results

Twenty studies comprising 18,469 patients were included in this meta-analysis. The incidence rate of MACE was 9.4% in the DCB group compared to 9.9% in the DES group, without a significant difference in the risk of MACE (OR = 0.97, 95% CI: 0.77 to 1.22, p = 0.78). Moreover, DCB significantly decreased MLD and NLG compared to DES, with the following values, respectively (MD= -0.19, 95% CI: -0.32 to -0.06, p < 0.001, and MD -0.21, 95% CI: -0.40 to -0.01, p = 0.04). On the other hand, DCB was associated with higher odds in the risk of in-segment binary restenosis (OR 1.66, 95% CI: 1.03 to 2.68, p = 0.04).

Conclusion

DCB is an alternative approach to DES in the management of small CAD and should be validated in daily clinical practice.

Prospero registration

CRD42023413068.